Cell & Gene: The Podcast An Interview with Dr. Peter Marks
Jan 5, 2023
Dr. Peter Marks, Director of CBER at the FDA, talks about innovations in clinical development, engaging with the FDA for streamlined manufacturing, and the importance of early communication. He discusses plans for 2023, personal hobbies like sailing, and the dedication to advancing cell and gene therapies.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Evolution of Cell and Gene Therapies at the FDA
01:53 • 7min
Accelerating Medical Product Development Through Communication and Innovation
08:44 • 15min
Discussion on CBER's Plans for 2023 and Dr. Peter Marks' Hobbies
23:49 • 2min
Exploring Dedication to the Cell and Gene Space
25:58 • 2min